Outcomes of High-Risk Acute Promyelocytic Leukemia patients Treated with Arsenic Trioxide (ATO)/All Trans Retinoic Acid (ATRA) Based Induction and Consolidation Without Maintenance Phase

We present a retrospective analysis of 10 patients that were treated for high risk APL based on the consolidation treatment phase of APL 0406 study without subsequent maintenance. With a median follow up of 38 months, all patients remain in remission.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research